US 8598149
Optimizing mifepristone levels in plasma serum of patients suffering from mental disorders treatable with glucocorticoid receptor antagonists
granted A61KA61K31/56A61K31/567
Quick answer
US patent 8598149 (Optimizing mifepristone levels in plasma serum of patients suffering from mental disorders treatable with glucocorticoid receptor antagonists) held by Corcept Therapeutics Incorporated expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corcept Therapeutics Incorporated
- Grant date
- Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/56, A61K31/567, A61K31/575, A61P